Changes

Jump to: navigation, search

B-cell acute lymphoblastic leukemia - historical

923 bytes added, 17:49, 13 December 2018
m
Daunorubicin & Prednisone {{#subobject:aa10e0|Regimen=1}}
=Relapsed or refractory=
==Bacillus Calmette-Guérin (BCG) monotherapy {{#subobject:e05416|Regimen=1}}==
{| class="wikitable" style="float:right; margin-left: 5px;"
|-
|[[#top|back to top]]
|}
===Regimen {{#subobject:637e03|Variant=1}}===
{| class="wikitable" style="width: 100%; text-align:center;"
!style="width: 50%"|Study
!style="width: 50%"|[[Levels_of_Evidence#Evidence|Evidence]]
|-
|[https://www.sciencedirect.com/science/article/pii/S0140673669926488 Mathé et al. 1969]
| style="background-color:#91cf61" |Non-randomized
|-
|}
====Immunotherapy====
*[[Bacillus Calmette-Guérin (BCG)]]
===References===
# Mathé G, Amiel JL, Schwarzenberg L, Schneider M, Cattan A, Schlumberger JR, Hayat M, De Vassal F. Active immunotherapy for acute lymphoblastic leukaemia. Lancet. 1969 Apr 5;1(7597):697-9. [https://www.sciencedirect.com/science/article/pii/S0140673669926488 link to SD article] [https://www.ncbi.nlm.nih.gov/pubmed/4182654 PubMed]
 
==Daunorubicin & Prednisone {{#subobject:aa10e0|Regimen=1}}==
{| class="wikitable" style="float:right; margin-left: 5px;"
LookupUsers, editors, emailconfirmed
24,569
edits

Navigation menu